Close Menu

influenza

The CDC's assay will run on ABI's 7500 Fast Dx Real-Time PCR instrument or the research use only 7500 Real-Time PCR instrument.

The study, begun last year, will take longer than the June 2009 timeframe projected late last year. It calls for the NIH to analyze the ability of the Biosafety Level 4 lab to contain 13 toxins to be studied there, and ensure it can run safely.

Oregon Health and Science University will use a $41M grant to start a regional biodefense and infectious disease center.

The pact builds on an existing relationship between the firms to develop an influenza molecular diagnostic assay for use with a HandyLab instrument.

IP Update: Feb 19, 2009

Premium

USPTO Publishes Six RNAi-Related Patent Applications

The Athens, Ohio-based firm licensed novel yeast-based virus cloning technology that will be used for HIV pharmacogenomics and other disease areas.

A company official said Hong Kong may be the best place to conduct the phase I study since data collected may be used in both US and Chinese regulatory filings.

News Briefs: Feb 4, 2009

Premium

Cerenis, Montreal Heart Institute, UVA, Ortho Clinical, Mirna, UCSF, Case Western, Diagnostic Hybrids, iBridge Network, Ben Franklin Tech Partners, and more…

The legislation would protect companies that either base their corporate headquarters in Georgia, employ over 200 workers in manufacturing or research and development in the state, or have their principal place of research and development in Georgia.

A Whole New System

Premium

Now in its ninth year, the experiment that was the Institute for Systems Biology has become an established research organization known for its focus on translational science.

Pages

The New York Times looks at companies using genomic tools to try to quickly identify the cause of patients' infections.

The White House has asked for $2.5 billion in funding to address the COVID-19 outbreak, according to the Associated Press.

A resignation at the Marine Biological Laboratory highlights that institutions are unsure of how to handle researchers previously found to have violated codes of conduct, Nature News says.

In PNAS this week: immune responses that affect heart transplant rejection risk, gene variants associated with thiopurine toxicity, and more.